An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors

Cancer progression is linked to aberrant protein glycosylation due to the overexpression of several glycosylation enzymes. These enzymes are underexploited as potential anticancer drug targets and the development of rapid-screening methods and identification of glycosylation inhibitors are highly so...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez, Michael Russelle S., Zhou, Qingwen, Grijaldo, Sheryl Joyce B., Lebrilla, Carlito B., Nacario, Ruel C., Heralde, Francisco M., Rabajante, Jomar F., Completo, Gladys C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228227/
https://www.ncbi.nlm.nih.gov/pubmed/35744954
http://dx.doi.org/10.3390/molecules27123834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228227/
https://www.ncbi.nlm.nih.gov/pubmed/35744954
http://dx.doi.org/10.3390/molecules27123834

Ejemplares similares